We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+9.9%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$6.29B
AUM Growth
+$523M
Cap. Flow
+$48.1M
Cap. Flow %
0.77%
Top 10 Hldgs %
19.64%
Holding
150
New
10
Increased
74
Reduced
45
Closed
16

Top Buys

Rank Stock Value
1
WEX icon
WEX
WEX
+$50.3M
2
PTC icon
PTC
PTC
+$40.9M
3
TUP
Tupperware Brands Corporation
TUP
+$39.1M
4
CAB
Cabela's Inc
CAB
+$34.7M
5
ROK icon
Rockwell Automation
ROK
+$34.3M

Top Sells

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$68.3M
2
MEAS
MEASUREMENT SPECIALTIES INC
MEAS
+$63.2M
3
K
Kellanova
K
+$38M
4
INTU icon
Intuit
INTU
+$27.9M
5
BJRI icon
BJ's Restaurants
BJRI
+$27.8M

Sector Composition

Rank Sector Weight
1 Healthcare 19.89%
2 Financials 16.83%
3 Technology 13.07%
4 Industrials 11.76%
5 Consumer Discretionary 11.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XPRO icon
101
Expro Ltd
XPRO
$1.66B
$24.5M 0.39%
245,165
+30,012
+14% +$3.19M
HELE icon
102
Helen of Troy
HELE
$656M
$24.1M 0.38%
369,655
+140,075
+61% +$8.62M
ACH
103
Accendra Health
ACH
$254M
$23.6M 0.38%
671,400
-4,320
-0.6% -$145K
NBTB icon
104
NBT Bancorp
NBTB
$2.82B
$22.3M 0.36%
849,510
-15,270
-2% -$377K
PODD icon
105
Insulet
PODD
$11.8B
$21.3M 0.34%
461,355
+185,150
+67% +$7.92M
ACET
106
DELISTED
Aceto Corp
ACET
$20.9M 0.33%
961,510
+43,550
+5% +$911K
WAT icon
107
Waters Corp
WAT
$37.3B
$20.8M 0.33%
+184,140
New +$20.2M
RDEN
108
DELISTED
ELIZABETH ARDEN INC
RDEN
$20.4M 0.32%
952,535
+42,625
+5% +$757K
RP
109
DELISTED
RealPage, Inc.
RP
$19.4M 0.31%
884,695
-1,381,780
-61% -$27.4M
AVD icon
110
American Vanguard Corp
AVD
$68.7M
$18.7M 0.3%
1,612,950
+21,435
+1% +$237K
LDL
111
DELISTED
Lydall, Inc.
LDL
$16M 0.25%
+486,715
New +$14.1M
CHD icon
112
Church & Dwight Co
CHD
$23.7B
$14.2M 0.23%
360,000
-107,060
-23% -$3.95M
CHRD icon
113
Chord Energy
CHRD
$7.68B
$13.3M 0.21%
805,480
+473,090
+142% +$11.7M
QGENF
114
DELISTED
QIAGEN NV
QGENF
$13.2M 0.21%
562,705
-526,095
-48% -$12.3M
BIO icon
115
Bio-Rad Laboratories Class A
BIO
$8.76B
$13.1M 0.21%
108,830
-593,695
-85% -$68.3M
LMNX
116
DELISTED
Luminex Corp
LMNX
$12.7M 0.2%
675,050
-1,137,790
-63% -$21.6M
BFAM icon
117
Bright Horizons
BFAM
$4.35B
$10.6M 0.17%
+224,970
New +$9.92M
AREX
118
DELISTED
Approach Resources Inc.
AREX
$8.41M 0.13%
1,316,450
-1,174,525
-47% -$11.3M
NOG icon
119
Northern Oil and Gas
NOG
$2.29B
$705K 0.01%
12,478
-77,505
-86% -$7.44M
JBTM
120
JBT Marel
JBTM
$7.35B
$550K 0.01%
+16,725
New +$512K
PM icon
121
Philip Morris
PM
$309B
$367K 0.01%
4,500
– –
DEO icon
122
Diageo
DEO
$49.6B
$342K 0.01%
3,000
+800
+36% +$93K
SU icon
123
Suncor Energy
SU
$77.7B
$302K ﹤0.01%
9,500
– –
ESRX
124
DELISTED
Express Scripts Holding Company
ESRX
$271K ﹤0.01%
3,200
-2,000
-38% -$156K
BP icon
125
BP
BP
$112B
$229K ﹤0.01%
7,231
-104
-1% -$3.5K
2 3 4
5
6

Similar funds

PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return

Champlain Investment Partners's Q4 2014 Portfolio in Review

As of Q4 2014, Champlain Investment Partners held 150 positions worth $6.29B, up 9.1% from $5.76B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Champlain Investment Partners's Q4 2014 filing shows 10 new, 74 increased, 45 reduced and 16 closed positions. Its largest new stake was PTC: 1,103,580 shares worth $40.4M. The largest sale was Bio-Rad Laboratories Class A, an estimated $68.3M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Financials and Technology.

  • Champlain Investment Partners's largest Q4 2014 buy was PTC: 1,103,580 shares worth $40.4M.
  • Champlain Investment Partners added most to WEX in Q4 2014, an estimated $50.3M increase.
  • Champlain Investment Partners's biggest Q4 2014 reduction was Bio-Rad Laboratories Class A, cutting an estimated $68.3M.
  • Champlain Investment Partners fully exited MEASUREMENT SPECIALTIES INC in Q4 2014, selling an estimated $63.2M.
  • Champlain Investment Partners's ten largest holdings make up 20% of its $6.29B portfolio in Q4 2014.
  • Champlain Investment Partners opened 10 new positions and closed 16 in Q4 2014.
  • Champlain Investment Partners's portfolio value rose 9.1% quarter-over-quarter to $6.29B.

Based on Champlain Investment Partners's 13F filing for Q4 2014, filed 11 Feb 2015.